How, when, and where to utilize erlotinib, afatinib, and gefitinib in EGFR positive NSCLC

In this presentation from the 21st Annual Perspectives in Thoracic Oncology, Dr. Vera Hirsh discusses how, when, and where to utilize erlotinib, afatinib, and gefitinib in EGFR-positive non-small cell... Author: imedex Added: 05/05/2017
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts